Building The Talent Pipeline Starts With Access For All
AstraZeneca CMO Ann Taylor Discusses Top Qualities Needed For The Biopharma Industry Of Tomorrow And Leading By Example In STEM Education
Executive Summary
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
You may also be interested in...
In Vivo’s Deals Of The Year 2020: Cast Your Vote!
It is time for In Vivo's 13th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.
Deals Shaping The Medical Industry, December 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2020. Data provided by Biomedtracker.
Execs On The Move, Dec 2020
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Need a specific report? 1000+ reports available
Buy Reports